PB2271: GERMLINE LOSS OF RHOG IDENTIFIES ITS ROLE AS AN ESSENTIAL REGULATOR OF HUMAN LYMPHOCYTE CYTOTOXICITY

• A. Kalinichenko,
• G. P. Casoni,
• L. Dupré,
• L. Trotta,
• J. Huemer,
• D. Galgano,
• Y. German,
• B. Haladik,
• J. Pazmandi,
• M. Thian,
• Ö. Yüce Petronczki,
• S. C. Chiang,
• M. Taskinen,
• A. Hekkala,
• S. Kauppila,
• O. Lindgren,
• T. Tapiainen,
• M. J. Kraakman,
• K. Vettenranta,
• A. J. Lomakin,
• J. Saarela,
• M. R. Seppänen,
• Y. T. Bryceson,
• K. Boztug

Affiliations

A. Kalinichenko

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

G. P. Casoni

2 Karolinska Institutet, Stockholm, Sweden

L. Dupré

3 INFINITy (Toulouse Institute for Infectious and Inflammatory Diseases), Toulouse, France

L. Trotta

4 Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland

J. Huemer

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

D. Galgano

2 Karolinska Institutet, Stockholm, Sweden

Y. German

3 INFINITy (Toulouse Institute for Infectious and Inflammatory Diseases), Toulouse, France

B. Haladik

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

J. Pazmandi

5 Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria

M. Thian

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

Ö. Yüce Petronczki

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

S. C. Chiang

2 Karolinska Institutet, Stockholm, Sweden

M. Taskinen

6 8Oulu University Hospital and University of Oulu

A. Hekkala

7 Oulu University Hospital and University of Oulu, Oulu

S. Kauppila

7 Oulu University Hospital and University of Oulu, Oulu

O. Lindgren

7 Oulu University Hospital and University of Oulu, Oulu

T. Tapiainen

7 Oulu University Hospital and University of Oulu, Oulu

M. J. Kraakman

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

K. Vettenranta

8 Rare Disease and Pediatric Research Centers, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

A. J. Lomakin

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria

J. Saarela

4 Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland

M. R. Seppänen

8 Rare Disease and Pediatric Research Centers, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Y. T. Bryceson

2 Karolinska Institutet, Stockholm, Sweden

K. Boztug

1 St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria